The rapid convergence of advanced medical device engineering and artificial intelligence driven clinical decision systems has created a new regulatory, ethical, and operational landscape for modern healthcare. High risk implantable and diagnostic devices approved through the United States Food and Drug Administration pathways such as Premarket Approval and Humanitarian Device Exemption programs illustrate how technological innovation in medicine is governed through rigorous safety, effectiveness, and post approval surveillance frameworks. Simultaneously, the expansion of artificial intelligence in clinical environments introduces new layers of complexity, particularly in relation to data integrity, cybersecurity, accountability, and trust in automated decision making. This article presents an integrated and theoretically grounded analysis of these intersecting domains by drawing exclusively on regulatory documentation from the United States Food and Drug Administration and a multidisciplinary body of peer reviewed and professional literature on healthcare economics, artificial intelligence ethics, cybersecurity, clinical logging, signal processing, cryptographic security, and intelligent supply chain management.

The study develops a unified analytical framework that links regulatory compliance in medical devices with emerging governance models for artificial intelligence based clinical systems. By examining regulatory records associated with multiple approved devices, including those evaluated under the Premarket Approval and Humanitarian Device Exemption processes, the paper demonstrates how the concepts of safety, probable benefit, effectiveness, and post market surveillance have evolved into continuous lifecycle governance structures. These structures increasingly resemble the accountability and auditability requirements proposed for artificial intelligence systems in clinical practice. The analysis further integrates cost measurement theory from value based healthcare, highlighting how economic evaluation is inseparable from regulatory and ethical oversight in determining whether technological innovations truly serve patient welfare and health system sustainability.

The paper also explores how engineering advances in areas such as error correction coding, noise reduction in imaging systems, and cryptographic security form the technical foundation upon which regulatory trust is built. Without reliable signal processing, secure data transmission, and tamper resistant logging, neither high risk medical devices nor artificial intelligence driven diagnostics can meet the evidentiary standards demanded by regulatory agencies or ethical frameworks. Furthermore, the growing use of artificial intelligence and computer vision in supply chains for healthcare related goods introduces another layer of governance, requiring alignment between logistics efficiency, cybersecurity, and regulatory traceability.